SCHIZOPHRENIA: UNRAVELING THE CHALLENGES AND TREATMENT

Authors

  • Douglas Ribeiro de Sá Medicina Universidade Federal do Tocantins
  • Francisco Igor Ribeiro Cerqueira Medicina Universidade Maria auxiliadora
  • Anderson Kretschmer Medicina Universidade Federal de São Paulo
  • Francisco de Assis Muniz de Oliveira Medicina Universidad Leonardo Da Vinci
  • Glenda Ferreira Leite Medicina Faculdade Metropolitana de Manaus
  • Camile Brasil Soares Gondim Medicina Faculdade Metropolitana de Manaus
  • Raul De Carvalho Nunes Martins Medicina Universidade Brasil
  • Larissa Maria Salvi Medicina Veterinária Centro Universitário Mater Dei
  • Milena dos Santos Máximo Medicina Universidad Sudamericana
  • Walter Rocha Passos Nieto Medicina Universidad Politecnica y Artistica del Paraguay
  • Daniel Abner Araujo Silva Medicina Universidad Maria Auxiliadora
  • Aliny Cristiani Prado Moreno Medicina Universidade Estácio de Sá

DOI:

https://doi.org/10.36557/2674-8169.2024v6n8p842-853

Keywords:

Schizophrenia, Stigmas, Treatment.

Abstract

Objective: To discuss, through scientific evidence, the challenges and treatment of schizophrenia. Methods: This is a qualitative integrative literature review. The research involved searching the following databases: SCIELO, LILACS, BDENF, and MEDLINE, using the health science descriptors: "Schizophrenia," "Stigmas," and "Treatment." Inclusion criteria were: articles published between 2014 and 2024, with full-text access freely available, and articles in Portuguese, English, and Spanish related to the theme. Exclusion criteria were: duplicate, incomplete articles, abstracts, reviews, debates, articles published in conference proceedings, and articles not available in full. Results: The integrative literature review revealed several significant challenges in the treatment of schizophrenia. Firstly, the stigma associated with the disease remains a significant barrier, affecting both public perception and patients' self-esteem, and negatively influencing treatment adherence. Scientific evidence shows that despite therapeutic advances, treatment effectiveness is often limited by patients' lack of adherence due to the side effects of antipsychotic medications and inadequate psychosocial support. Conclusion: It is concluded that schizophrenia presents complex challenges that require a multifaceted approach. The literature review highlights that, in addition to pharmacological advances, it is crucial to combat stigma and promote treatment adherence through continuous psychosocial support and personalized interventions. Rehabilitation programs and early interventions are essential to improve long-term outcomes. Thus, for more effective treatment of schizophrenia, an integrated health system combining medical treatments with psychosocial support is necessary, ensuring a comprehensive and patient-centered approach.

Downloads

Download data is not yet available.

References

MELO, AHF; FREITAS, F. Esquizofrenia, modelo biomédico e cobertura de mídia. Saúde em Debate, v. 136, pág. 96–109, 2023.

KHUDYAKOVA, M. et al. Base de dados de diversidade discursiva (3D) para pesquisa em clínica linguística: projeto, construção e análise. Bakhtiniana Revista de Estudos do Discurso, v. 1, pág. 32–57, 2023.

OMAR-MARTÍNEZ, E. et al. Neurolinguistics evidence of oral discourse in schizophrenic patients. Comparative analysis with Wernicke’s aphasia. Zenodo, , 2024. Disponível em: <http://dx.doi.org/10.5281/ZENODO.10198402>

CASAÑAS, MM Enfermedades associadas e indicadores metabólicos em pessoas com esquizofrenia. Revista cubana de medicina , v. 62, n. 4, 2023.

INFANTE-TORRES, D. et al. Construction and validation of a scale of stigma against individuals diagnosed with schizophrenia. Terapia psicológica, v. 41, n. 3, p. 343–361, 2023.

ROSA, D. C. J. et al. “Paciente-problema”: imaginário coletivo de enfermeiros acerca do usuário com diagnóstico de esquizofrenia. Physis (Rio de Janeiro, Brazil), v. 31, n. 1, 2021.

VERAS, A. B. The dilemma of antipsychotics prescription for schizophrenia and the efforts to develop a more comprehensive approach of psychosis. Jornal brasileiro de psiquiatria, v. 71, n. 3, p. 166–167, 2022.

FULONE, I.; SILVA, M. T.; LOPES, L. C. Use of atypical antipsychotics in the treatment of schizophrenia in the Brazilian National Health System: a cohort study, 2008-2017. Epidemiologia e servicos de saude: revista do Sistema Unico de Saude do Brasil, v. 32, n. 1, 2023.

PSCHEIDT, S. L. et al. Doenças cardiovasculares e uso de antipsicóticos na esquizofrenia: uma revisão. Jornal brasileiro de psiquiatria, v. 71, n. 3, p. 253–272, 2022.

PIMENTEL MELO, F. C. et al. ANÁLISE DAS INTERNAÇÕES PSIQUIÁTRICAS PELO SUS NO PIAUÍ, BRASIL, DE 2008 A 2020. Cogitare Enfermagem, n. 27, p. 1–13, 2022.

ROCHA, H. A. DA et al. Internações psiquiátricas pelo Sistema Único de Saúde no Brasil ocorridas entre 2000 e 2014. Revista de saude publica, v. 55, p. 14, 2021.

SOUZA, M.T; SILVA, M.D; CARVALHO, R. Revisão integrativa: o que é e como fazer.Einstein, v. 8, p. 102-106, 2010.

Published

2024-08-06

How to Cite

Sá , D. R. de, Cerqueira , F. I. R., Kretschmer , A., Oliveira , F. de A. M. de, Leite, G. F., Gondim, C. B. S., Martins, R. D. C. N., Salvi , L. M., Máximo, M. dos S., Nieto , W. R. P., Silva, D. A. A., & Moreno, A. C. P. (2024). SCHIZOPHRENIA: UNRAVELING THE CHALLENGES AND TREATMENT. Brazilian Journal of Implantology and Health Sciences, 6(8), 842–853. https://doi.org/10.36557/2674-8169.2024v6n8p842-853